In Part 2 of this Exclusive Interview, Dr. Osama Hamdy talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about ways to work within cultural traditions to improve nutrition and eating habits thus affecting diabetes management.

In this week's Homerun Slides, an explanation of some important diabetes trials such as EPPIC, SUN, BEACON, etc.

Nicotinic acid (niacin) has been used for more than 50 years to lower LDL-C and TGs, and increase the level of HDL-C. Indeed, niacin is the most potent HDL-C-raising pharmacologic agent available. Of note, we still, at this late time in the life of niacin, do not have definitive evidence regarding its mechanism(s) at the molecular level.

I first got my CDE back in 2004. Before that I was the proud holder of a certificate from the Lifescan Pharmacist Diabetes education program that they were offering to us in Milpitas, CA. After I became a CDE, I desperately wanted to become a pump trainer. I talked to …

Meal sequencing may decrease glucose levels and insulin utilization.

Increased cardio risk of Saxagliptin found during trial prompts FDA decision.

Trial results promising, but DKA still a concern with use of new once-daily pills.

Philadelphia youth see rise in diagnosis; especially for African Americans, by 70%.

Common osteoarthritis treatment may be beneficial in lowering HbA1c.

By Featured Writer Sheri R. Colberg, PhD. As a clinical exercise researcher, I frequently have found it difficult to study exercise effects in people with health complications, even though this is critical information to know in order to make appropriate exercise guidelines. Try convincing your university Institutional Research Board, or IRB, that it is advisable to exercise people with eye issues like unstable proliferative retinopathy to find out if breath-holding, jumping, jarring, or head-down activities cause them to experience retinal hemorrhages. Understandably, that is not going to happen, nor should it.